A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism
Clinical trial NCT01653379 · COMPLETED
Trial details
- NCT number
- NCT01653379
- Sponsor
- Deltanoid Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-07-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.